Login / Signup

Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial.

Francesco CosentinoChristopher P CannonRobert FrederichDavid Z I CherneySamuel Dagogo-JackRichard E PratleyJames P MancusoMario MaldonadoNilo B CaterShuai WangDarren K McGuire
Published in: Circulation (2022)
Keyphrases
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • randomized controlled trial
  • adipose tissue
  • metabolic syndrome
  • skeletal muscle
  • glycemic control
  • double blind